Cedars-Sinai’s Chief Health Equity Officer Available for Interviews During AHA Health Equity Conference

Cedars-Sinai’s chief health equity officer will be available for interviews during the American Hospital Association: Accelerating Health Equity Conference, May 7-9 in Kansas City.

Women’s Health Month: Artificial Intelligence Can Improve OB-GYN Care

Cedars-Sinai investigators are using artificial intelligence (AI) to reduce serious health risks associated with pregnancy and childbirth and improve screening for some gynecological cancers.

Rutgers-Led Statewide Translational Research Institute Is Awarded $39.7 Million National Institutes of Health Grant

The National Institutes of Health (NIH) has awarded the Rutgers Institute for Translational Medicine and Science $39,673,786 over seven years to build and improve upon infrastructure that promotes clinical and translational science through the New Jersey Alliance for Clinical and Translational Science (NJ ACTS).

Mount Sinai Experts Available for Interview During Women’s Health Awareness Month

  Mount Sinai Experts Available for Interview During Women’s Health Awareness Month  As we continue to recognize May as Women’s Health Awareness Month, and kick off National Women’s Health Week on Sunday, May 12, I want to flag Mount Sinai…

Study led by ORNL informs climate resilience strategies in urban, rural areas

Local decision-makers looking for ways to reduce the impact of heat waves on their communities have a valuable new capability at their disposal: a new study on vegetation resilience.

من الممكن أن يؤثر داء الأمعاء الالتهابي على أشياء غير الأمعاء: يشرح الخبراء كيفية ذلك

يتعايش أكثر من 10 مليون شخص في أنحاء العالم مع داء الأمعاء الالتهابي، وهو حالة مزمنة تسبب حدوث التهاب في السبيل الهضمي، ولكنها يمكن أن تؤثر أيضًا في مناطق أخرى من الجسم.

Mount Sinai Scientists Unravel How Psychedelic Drugs Interact with Serotonin Receptors to Potentially Produce Therapeutic Benefits

Researchers at the Icahn School of Medicine at Mount Sinai have shed valuable light on the complex mechanisms by which a class of psychedelic drugs binds to and activates serotonin receptors to produce potential therapeutic effects in patients with neuropsychiatric disorders such as depression and anxiety.

GUIDE team develops computational approach to redesign antibodies for broader effectiveness against viral pandemics

In a groundbreaking development for addressing future viral pandemics, a multi-institutional team involving Lawrence Livermore National Laboratory researchers has successfully combined an artificial intelligence-backed platform with supercomputing to redesign and restore the effectiveness of antibodies whose ability to fight viruses has been compromised by viral evolution. The work was published in the journal Nature.

Disadvantaged entrepreneurs often fear success, but new research can help

When low-income entrepreneurs start their own businesses, they frequently fear failure — a well-documented phenomenon. But over time, they may also fear success, given the costs and unknowns it can bring, and this barrier to growth is under-studied and underappreciated. A new study from a Keough School of Global Affairs expert breaks new ground by explaining this fear and offers five recommendations to help entrepreneurs overcome it and move out of poverty.

Brian Schaffner Named a 2024 Andrew Carnegie Fellow

Brian Schaffner, a political science professor and Newhouse Professor of Civic Studies in the School of Arts and Sciences and the Jonathan M. Tisch College of Civic Life, has been named to the 2024 class of Andrew Carnegie Fellows by Carnegie Corporation of New York.

FAU Researchers Receive $1M in FDOH Grants to Fight Alzheimer’s Disease

With this funding, FAU researchers will shed light on the biological functions of Alzheimer’s disease (AD) by taking advantage of synthetic chemistry strategies; provide an innovative online screening tool for older drivers with cognitive decline; and gain a deeper understanding of the role of brain cholesterol in AD.

Biomarker found to help identify cells that can repair damaged blood vessels

Researchers have discovered a protein marker to help identify cells able to repopulate in patients with damaged blood vessels. Their findings, recently published in Circulation, could lead to new therapies for people with endothelial dysfunction, a type of disorder that contributes to coronary artery disease that may occlude with plaque and lack ability to carry sufficient blood into the heart tissue causing a heart attack.

NeuroTherapia Receives Grant from Alzheimer’s Association for Development of First-in-Class Drug for Alzheimer’s Disease

NeuroTherapia, an early-stage clinical pharmaceutical company, announced today that it has received a grant from the Alzheimer’s Association Part the Cloud program for the development of its first-in-class drug, NTRX-07, for the treatment of Alzheimer’s disease (AD).

ECHO Discovery Webinar: Unveiling Maternal Health Disparities: Addressing the Impact of Racism

Dr. Ndidiamaka Amutah-Onukagha explores the historical and contemporary reproductive struggles faced by women of color in the United States, highlighting challenges such as medical bias, unequal access to resources, and inadequate prenatal care, while also discussing environmental influences on maternal and child health and community engagement strategies.

Study Sheds Light on Cancer Cell ‘Tug-of-War’

In APL Bioengineering, researchers used a breast cancer cell line panel and primary tumor explants from breast and cervical cancer patients to examine two different cellular contractility modes: one that generates collective tissue surface tension that keeps cell clusters compact and another, more directional, contractility that enables cells to pull themselves into the extracellular matrix.

Game-changer in cancer science: how TP53gene loss drives gastric cancer evolution

“The independent research groups, led by Prof. Scott W. Lowe and Christina Curtis,respectively, have uncovered a similar definitive pathway in the progression of gastric cancer (GC) initiated with loss of the TP53 gene, representing a milstone in understanding the early stages of this deadly disease”. Dr. Zhaocai Zhou, head of a GC laboratory from Fudan University, stated.

American Academy of Dermatology survey shows outdoor workers more at risk for skin cancer than average Americans

A recent American Academy of Dermatology survey of more than 1,000 U.S. adults revealed that outdoor workers — like those who work in construction, landscaping, emergency medical services, and postal delivery — are far more likely to get sunburned and tanned, putting themselves at increased risk for skin cancer, compared to the average American.

Researchers Engineer Yeast to Transport Medicines and Lower Inflammation for Potential Treatment of Inflammatory Bowel Disease

Researchers at the UNC Eshelman School of Pharmacy and the UNC School of Medicine have engineered a probiotic yeast that enhances probiotic absorption in the gut and has the ability to suppress and even reverse inflammation in animals.